Jean Hurteau

Papers

Total Citations

H-Index

About

Jean Hurteau is a prominent gynecologic oncologist whose research focuses on optimizing surgical outcomes and thromboprophylaxis in women with gynecologic cancers. Her key contributions center on the perioperative management of endometrial cancer patients, particularly regarding venous thromboembolism (VTE) risk after minimally invasive surgery. Her most cited work, a 2017 study on extended pharmacologic prophylaxis following robotic surgery for endometrial cancer (29 citations), demonstrated that prolonged anticoagulation significantly reduces VTE events without increasing major bleeding complications. This finding has direct clinical implications, helping to shape evidence-based guidelines for postoperative care in this population. Hurteau’s research bridges surgical innovation and patient safety, addressing a critical gap in understanding thrombotic risks unique to robotic-assisted procedures. Beyond this landmark study, her broader portfolio includes investigations into surgical techniques, chemotherapy regimens, and survivorship issues in gynecologic malignancies. With a career dedicated to improving outcomes through rigorous clinical research, Hurteau’s work has influenced practice patterns and informed the design of larger multicenter trials. Her contributions underscore the importance of tailored prophylaxis strategies in reducing preventable complications, making her a respected voice in the field of gynecologic oncology.